• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善痛风患者降尿酸治疗接受率的干预措施:一项系统评价

Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review.

作者信息

Gill Iqbal, Dalbeth Nicola, 'Ofanoa Malakai, Goodyear-Smith Felicity

机构信息

Faculty of Medical & Health Science, University of Auckland, Auckland, New Zealand.

Bone and Joint Research Group, Faculty of Medical and Health Science, The University of Auckland, Auckland, New Zealand.

出版信息

BJGP Open. 2020 Aug 25;4(3). doi: 10.3399/bjgpopen20X101051. Print 2020 Aug.

DOI:10.3399/bjgpopen20X101051
PMID:32636201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7465587/
Abstract

BACKGROUND

Gout treatment is suboptimal despite available therapy, with low levels of initiation and persistence of urate-lowering therapy (ULT) in many patients.

AIM

To identify all interventions that have attempted to improve the uptake of ULT and analyse the clinical outcomes.

DESIGN & SETTING: A systematic review of international articles published in English.

METHOD

A systematic search was conducted through MEDLINE, Embase, CINAHL Plus, and Scopus databases to identify all studies on relevant interventions for gout. Interventions were included if they aimed to address patient adherence with serum urate (SU) level as an outcome. This included patient education, practitioner monitoring, medication titration, SU monitoring, and ongoing patient engagement and follow-up. Follow-up studies to original interventions and those with only an abstract available were included.

RESULTS

Twenty articles met the inclusion criteria, describing outcomes of 18 interventions conducted in primary care settings: six nurse-led, five pharmacist-led, and seven multidisciplinary, multifaceted interventions. Improvement in SU levels was observed in all interventions. Nurse-led interventions were effective at empowering patients as they addressed illness perceptions and provided education, advice, and telephone follow-up. Pharmacist-led interventions primarily aimed to monitor patients, alter medication dosage, and provide automated telephone follow-up. Various multifaceted programmes involving a range of providers resulted in increased sustained use of urate-lowering medication.

CONCLUSION

A nurse-led approach focusing on patient understanding about gout is the most effective in achieving improved patient adherence, and lowered SU levels among patients. An intervention should include patient education and follow-up components.

摘要

背景

尽管有可用的治疗方法,但痛风治疗效果仍不理想,许多患者的降尿酸治疗(ULT)起始率和持续率较低。

目的

确定所有试图提高ULT使用率的干预措施,并分析临床结果。

设计与设置

对以英文发表的国际文章进行系统综述。

方法

通过MEDLINE、Embase、CINAHL Plus和Scopus数据库进行系统检索,以确定所有关于痛风相关干预措施的研究。如果干预措施旨在以血清尿酸(SU)水平作为结果来解决患者依从性问题,则纳入该干预措施。这包括患者教育、医生监测、药物滴定、SU监测以及持续的患者参与和随访。纳入对原始干预措施的随访研究以及那些只有摘要可用的研究。

结果

20篇文章符合纳入标准,描述了在初级保健机构中进行的18项干预措施的结果:6项由护士主导,5项由药剂师主导,7项多学科、多方面的干预措施。所有干预措施均观察到SU水平有所改善。由护士主导的干预措施在增强患者能力方面是有效的,因为它们解决了患者对疾病的认知,并提供了教育、建议和电话随访。由药剂师主导的干预措施主要旨在监测患者、改变药物剂量并提供自动电话随访。各种涉及一系列提供者的多方面项目导致降尿酸药物的持续使用增加。

结论

以护士为主导、注重患者对痛风的理解的方法在提高患者依从性和降低患者SU水平方面最为有效。一项干预措施应包括患者教育和随访部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/446f/7465587/f7d6d64299e8/bjgpopen-4-1051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/446f/7465587/f7d6d64299e8/bjgpopen-4-1051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/446f/7465587/f7d6d64299e8/bjgpopen-4-1051-g001.jpg

相似文献

1
Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review.改善痛风患者降尿酸治疗接受率的干预措施:一项系统评价
BJGP Open. 2020 Aug 25;4(3). doi: 10.3399/bjgpopen20X101051. Print 2020 Aug.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Treatment approaches and adherence to urate-lowering therapy for patients with gout.痛风患者的治疗方法及对降尿酸治疗的依从性
Patient Prefer Adherence. 2017 Apr 19;11:795-800. doi: 10.2147/PPA.S97927. eCollection 2017.
4
A nurse-led, rheumatologist-assisted telemedicine intervention for dose escalation of urate-lowering therapy in gout.护士主导、风湿病专家协助的远程医疗干预在痛风中增加尿酸降低治疗剂量。
Int J Rheum Dis. 2020 Aug;23(9):1136-1144. doi: 10.1111/1756-185X.13855. Epub 2020 Jun 1.
5
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout.降尿酸治疗的处方和剂量,而不是患者行为,是与痛风患者血清尿酸目标值相关的关键可改变因素。
BMC Musculoskelet Disord. 2012 Sep 16;13:174. doi: 10.1186/1471-2474-13-174.
6
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
7
Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review.改善痛风患者降尿酸治疗依从性的临床干预措施:系统评价。
Int J Pharm Pract. 2022 Jun 25;30(3):215-225. doi: 10.1093/ijpp/riac025.
8
Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study.门诊护理药师主导的优化尿酸降低途径随机评估(RAmP-UP)研究的原理与设计
Contemp Clin Trials. 2016 Sep;50:106-15. doi: 10.1016/j.cct.2016.07.019. Epub 2016 Jul 20.
9
Lowering Serum Urate With Urate-Lowering Therapy to Target and Incident Fracture Among People With Gout.降尿酸治疗以达标血尿酸水平与痛风患者骨折事件的关系。
Arthritis Rheumatol. 2023 Aug;75(8):1456-1465. doi: 10.1002/art.42504. Epub 2023 May 25.
10
Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.护士主导的护理在教育和参与患者方面的疗效和成本效益,以及针对目标尿酸降低策略与常规护理相比,在痛风中的应用:一项随机对照试验。
Lancet. 2018 Oct 20;392(10156):1403-1412. doi: 10.1016/S0140-6736(18)32158-5.

引用本文的文献

1
Pacific community's perceptions on how to improve uptake of urate-lowering therapy for Pacific gout patients.太平洋地区社群对如何提高太平洋痛风患者降尿酸治疗接受率的看法。
Int J Equity Health. 2025 Apr 2;24(1):91. doi: 10.1186/s12939-025-02465-8.
2
The Gut Microbiome in Hyperuricemia and Gout.高尿酸血症和痛风中的肠道微生物群
Arthritis Rheumatol. 2025 Jan 19. doi: 10.1002/art.43118.
3
Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares.在痛风发作住院期间实施达标降尿酸治疗。

本文引用的文献

1
Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach.通过协作式初级保健方法,促进新西兰北地毛利人痛风的公平预防和管理。
J Prim Health Care. 2019 Jul;11(2):117-127. doi: 10.1071/HC18082.
2
The challenges of managing gout in primary care: Results of a best-practice audit.基层医疗中痛风管理的挑战:最佳实践审核结果。
Aust J Gen Pract. 2019 Sep;48(9):631-637. doi: 10.31128/AJGP-04-19-4909.
3
Pharmacist-managed titration of urate-lowering therapy to streamline gout management.
Rheumatology (Oxford). 2024 Aug 1;63(8):2222-2229. doi: 10.1093/rheumatology/kead574.
4
Gout in an Obese Patient with Nonalcoholic Steatohepatitis on a Thiazide Diuretic and Association Between Hyperuricemia and Nonalcoholic Steatohepatitis: A Case Report.一名服用噻嗪类利尿剂的非酒精性脂肪性肝炎肥胖患者的痛风以及高尿酸血症与非酒精性脂肪性肝炎之间的关联:病例报告
Cureus. 2023 May 18;15(5):e39207. doi: 10.7759/cureus.39207. eCollection 2023 May.
5
Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review.以痛风缓解为降尿酸治疗目标:一项批判性综述
Pharmaceuticals (Basel). 2023 May 23;16(6):779. doi: 10.3390/ph16060779.
6
What are the core recommendations for gout management in first line and specialist care? Systematic review of clinical practice guidelines.一线治疗和专科护理中痛风管理的核心建议有哪些?临床实践指南的系统评价。
BMC Rheumatol. 2023 Jun 15;7(1):15. doi: 10.1186/s41927-023-00335-w.
7
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout.开发并使用基于网络的个体化患者工具以支持痛风患者降尿酸治疗的依从性
BMC Med Inform Decis Mak. 2022 Apr 7;22(1):95. doi: 10.1186/s12911-022-01833-6.
8
Professionals' perspectives on existing practice and conditions for nurse-led gout care based on treatment recommendations: a qualitative study in primary healthcare.基于治疗建议的专业人员对现有护士主导的痛风护理实践和条件的看法:初级保健中的定性研究。
BMC Prim Care. 2022 Apr 7;23(1):71. doi: 10.1186/s12875-022-01677-z.
9
Development of a patient decision aid for the initiation of urate-lowering therapy in gout patients.开发一种用于痛风患者启动尿酸降低治疗的患者决策辅助工具。
RMD Open. 2022 Feb;8(1). doi: 10.1136/rmdopen-2021-001979.
10
Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol.太平洋干预提高痛风患者降尿酸治疗使用率的设计与实施:研究方案。
Int J Equity Health. 2021 Dec 23;20(1):262. doi: 10.1186/s12939-021-01601-4.
药师管理降尿酸治疗滴定以简化痛风管理。
Rheumatol Int. 2019 Sep;39(9):1637-1641. doi: 10.1007/s00296-019-04333-5. Epub 2019 May 30.
4
Prevention and treatment of gout.痛风的预防与治疗。
Nat Rev Rheumatol. 2019 Feb;15(2):68-70. doi: 10.1038/s41584-018-0149-7.
5
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.降尿酸治疗的依从性和结果:一项现场随机试验。
Am J Med. 2019 Mar;132(3):354-361. doi: 10.1016/j.amjmed.2018.11.011. Epub 2018 Nov 29.
6
Gout in Aotearoa New Zealand: the equity crisis continues in plain sight.新西兰奥特亚罗瓦的痛风:公平危机依然显而易见。
N Z Med J. 2018 Nov 9;131(1485):8-12.
7
Implication of nurse intervention on engagement with urate-lowering drugs: A qualitative study of participants in a RCT of nurse led care.护士干预对降尿酸药物使用的影响:一项护士主导护理 RCT 中参与者的定性研究。
Joint Bone Spine. 2019 May;86(3):357-362. doi: 10.1016/j.jbspin.2018.10.008. Epub 2018 Oct 27.
8
Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.护士主导的护理在教育和参与患者方面的疗效和成本效益,以及针对目标尿酸降低策略与常规护理相比,在痛风中的应用:一项随机对照试验。
Lancet. 2018 Oct 20;392(10156):1403-1412. doi: 10.1016/S0140-6736(18)32158-5.
9
Improved Gout Outcomes in Primary Care Using a Novel Disease Management Program: A Pilot Study.新型疾病管理方案改善初级保健中的痛风治疗结局:一项试点研究。
Arthritis Care Res (Hoboken). 2018 Nov;70(11):1679-1685. doi: 10.1002/acr.23544.
10
Education and non-pharmacological approaches for gout.痛风的教育和非药物治疗方法。
Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i51-i58. doi: 10.1093/rheumatology/kex421.